Mitochondrial Cardiomyopathy Presenting as Dilated Phase of Hypertrophic Cardiomyopathy Diagnosed with Histological and Genetic Analyses.
Toshiki KunoSyohei ImaedaYohei AsakawaHiroshi NakamuraGenzou TakemuraDaisuke AsaharaAkira KanamoriTomoyuki KabutoyaYohei NumasawaPublished in: Case reports in cardiology (2017)
We report a case with 46-year-old man diagnosed with mitochondrial cardiomyopathy in the dilated phase of hypertrophic cardiomyopathy. Since cardiac magnetic resonance imaging, beta-methyl-p-123I-iodophenyl-pentadecanoic myocardial scintigraphy, and positron emission tomography/computed tomography revealed no remarkable findings, we performed electron microscopic examination, which aided in diagnosing mitochondrial cardiomyopathy. Muscle biopsy was also compatible with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes and DNA analysis also concluded it. Since muscle biopsy is less invasive for patients compared to endomyocardial biopsy, cardiologists need to consider it. The diagnosis of mitochondrial cardiomyopathy is helpful because it is a genetic condition and also for consideration of device therapy, as well as management for acute crisis.
Keyphrases
- hypertrophic cardiomyopathy
- computed tomography
- positron emission tomography
- left ventricular
- oxidative stress
- magnetic resonance imaging
- heart failure
- ultrasound guided
- skeletal muscle
- end stage renal disease
- ejection fraction
- chronic kidney disease
- atrial fibrillation
- public health
- liver failure
- genome wide
- stem cells
- bone marrow
- single molecule
- mesenchymal stem cells
- blood brain barrier
- dna methylation
- pet imaging
- circulating tumor
- patient reported outcomes
- drug induced
- subarachnoid hemorrhage
- smoking cessation